Surface markers of cancer stem cells (CSCs), such as CD44 72, 73 or CD133 74, have been used in NIR-PIT to kill aggressive subpopulations of cells in the tumor, resulting in good therapeutic effects. The gene discussed is CD44; the disease is cancer.